Woodline Partners LP Rocket Pharmaceuticals, Inc. Transaction History
Woodline Partners LP
- $9.97 Billion
- Q2 2024
A detailed history of Woodline Partners LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 561,966 shares of RCKT stock, worth $9.89 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
561,966Holding current value
$9.89 Million% of portfolio
0.12%Shares
5 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
91.9MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$311 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$161 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$109 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$102 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$76.2 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.33B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...